Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT03882970

Public ClinicalTrials.gov record NCT03882970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.

Study identification

NCT ID
NCT03882970
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,444 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2019 (Actual)
Primary completion
Dec 11, 2020 (Actual)
Completion
Jan 4, 2021 (Actual)
Last update posted
Jan 19, 2022

2019 – 2021

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arkansas Clinical Research Little Rock Arkansas 72205 —
Valley Research Fresno California 93720 —
National Research Institute Huntington Park California 90255 —
National Research Institute Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Valley Clinical Trials, Inc. Northridge California 91325 —
National Research Institute Panorama City California 91402 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Indago Research & Health Center, Inc. Hialeah Florida 33012 —
East Coast Clinical Research Jacksonville Florida 32204 —
East Coast Institute For Research Jacksonville Florida 32216 —
Bayside Clinical Research, LLC New Port Richey Florida 34655 —
East Coast Institute For Research Macon Georgia 31210 —
Sky Clinical Research Network Union City Georgia 30291 —
Elite Clinical Trials LLLP Blackfoot Idaho 83221 —
Humphreys Diabetes Center Boise Idaho 83702 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
Springfield Diabetes & Endocrine Center Springfield Illinois 62711 —
Crescent City Clinical Research Metairie Louisiana 70006 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
Troy Internal Medicine, PC Troy Michigan 48098 —
International Diabetes Center Minneapolis Minnesota 55416 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Palm Research Center Las Vegas Nevada 89128 —
Palm Research Center Las Vegas Nevada 89148 —
Aventiv Research Columbus Ohio 43213 —
The Corvallis Clinic P.C. Corvallis Oregon 97330 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Detweiler Family Medicine Lansdale Pennsylvania 19446 —
Office of Dr. Osvaldo Brusco Corpus Christi Texas 78414 —
Consano Clinical Research Shavano Park Texas 78231 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03882970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2022 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03882970 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →